Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 20/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.73 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.73 |
| ▸ | MCHR2 | Q969V1 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12340372 | 0.99 | MCHR1 (0.72) | MCHR1CYP3A4KCNH2MCHR2CYP2C19 | |
| Hydrochloric Acid SCHEMBL2963678 | 0.99 | MCHR1 (0.72) | MCHR1CYP3A4KCNH2MCHR2CYP2C19 | |
| SCHEMBL12339988 | 0.94 | MCHR1 (0.69) | MCHR1CYP3A4KCNH2MCHR2CYP2C19 | |
| SCHEMBL12339993 | 0.92 | MCHR1 (0.74) | MCHR1CYP3A4KCNH2MCHR2CYP2C19 | |
| SCHEMBL12340172 | 0.91 | MCHR1 (0.75) | MCHR1CYP3A4KCNH2MCHR2CYP2C19 | |
| Hydrochloric Acid SCHEMBL2955856 | 0.91 | MCHR1 (0.73) | MCHR1CYP3A4KCNH2MCHR2CYP2C19 | |
| Hydrochloric Acid SCHEMBL2968854 | 0.91 | MCHR1 (0.73) | MCHR1CYP3A4KCNH2MCHR2CYP2C19 | |
| SCHEMBL12339989 | 0.90 | MCHR1 (0.76) | MCHR1CYP3A4KCNH2CYP2C19 | |
| SCHEMBL2966144 | 0.90 | MCHR1 (0.60) | MCHR1CYP3A4KCNH2MCHR2CYP2C19 | |
| Hydrochloric Acid SCHEMBL2964674 | 0.89 | MCHR1 (0.75) | MCHR1CYP3A4KCNH2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8268868-B2 | 5-pyridinone substituted indazoles | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-09-18 | — | — | US | disclosed |
| US-8268868-B2 | 5-pyridinone substituted indazoles | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-09-18 | — | — | US | disclosed |
| US-20100105679-A1 | 5-PYRIDINONE SUBSTITUTED INDAZOLES | ALBANY MOLECULAR RESEARCH, INC. (US) | 2010-04-29 | — | — | US | disclosed |
| US-20100105679-A1 | 5-PYRIDINONE SUBSTITUTED INDAZOLES | ALBANY MOLECULAR RESEARCH, INC. (US) | 2010-04-29 | — | — | US | disclosed |
| WO-2008086404-A1 | 5-PYRIDINONE SUBSTITUTED INDAZOLES | ALBANY MOLECULAR RESEARCH, INC. (US) | 2008-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105679-A1 | 5-PYRIDINONE SUBSTITUTED INDAZOLES | CYP3A5, PDXK, PNPO | MCHR1 4525/4885CYP3A4 8/4885KCNH2 917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.